Safety of OMS103HP in Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction

PHASE3CompletedINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2011

Conditions
Anterior Cruciate Ligament Reconstruction
Interventions
DRUG

OMS103HP

Maximum of 13 bags of OMS103HP irrigation solution over a maximum of 2 hours

DRUG

Vehicle

Maximum of 13 bags of BSS irrigation over a maximum of 2 hours.

Trial Locations (10)

15203

University of Pittsburgh Medical Center, Pittsburgh

19140

Temple University Orthopedics, Philadelphia

27157

Wake Forest University Health Sciences, Winston-Salem

27710

Duke University, Durham

43221

Ohio State University Sports Medicine, Columbus

60612

Rush University, Chicago

80110

Colorado Orthopedic Consultants, PC, Englewood

80230

Advanced Orthopedic and Sports Medicine Specialists, Denver

90045

Kerlan-Jobe Orthopaedic Clinic, Los Angeles

94063

Sports, Orthopedic and Rehabilitation Medicine Associates (S.O.A.R.), Redwood City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Omeros Corporation

INDUSTRY

NCT00245271 - Safety of OMS103HP in Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction | Biotech Hunter | Biotech Hunter